Eris Lifesciences Ltd (ERIS)

Currency in INR
1,694.50
-30.95(-1.79%)
Closed·
ERIS Scorecard
Full Analysis
Impressive gross profit margins
ERIS is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
1,671.101,725.85
52 wk Range
1,120.351,909.55
Key Statistics
Bid/Ask
1,680.00 / 1,694.50
Prev. Close
1,725.45
Open
1,710.05
Day's Range
1,671.1-1,725.85
52 wk Range
1,120.35-1,909.55
Volume
16.52K
Average Volume (3m)
9.6K
1-Year Change
55.82%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
ERIS Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Trading at a high earnings multiple

Eris Lifesciences Ltd News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Sell

Eris Lifesciences Ltd Company Profile

Eris Lifesciences Limited, together with its subsidiaries, provides domestic branded formulations for chronic and sub-chronic therapies in India and internationally. The company offers various branded formulations in various therapeutic areas, such as anti–diabetes, cardiovascular, nutrition, dermatology, neuroscience, gynecology, nephrology, and oncology, as well as central nervous system, women’s health, and vitamins/minerals/nutrients. It also provides patient care services, including ambulatory blood pressure measurement, ambulatory electrocardiogram measurement, continuous glucose monitoring system, sleep study, and anti-natal care solutions. It offers its products through wholesale drug distributors, stockists, retail and e-commerce pharmacies. Eris Lifesciences Limited was incorporated in 2007 and is headquartered in Ahmedabad, India.

Employees
3354
Market
India

Compare ERIS to Peers and Sector

Metrics to compare
ERIS
Peers
Sector
Relationship
P/E Ratio
59.7x30.1x−0.5x
PEG Ratio
38.200.880.00
Price/Book
8.1x3.8x2.6x
Price / LTM Sales
7.9x4.4x3.3x
Upside (Analyst Target)
10.1%13.0%43.5%
Fair Value Upside
Unlock6.0%6.9%Unlock

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 28.41%
Dividend Yield
0.43%
Industry Median 0.73%
Annualised payout
7.35
Paid unevenly
5-Years Growth
-
Growth Streak

Earnings

Latest Release
Aug 05, 2025
EPS / Forecast
8.70 / 8.65
Revenue / Forecast
7.73B / 8.11B
EPS Revisions
Last 90 days

ERIS Income Statement

People Also Watch

945.00
NATP
+2.96%
2,062.80
GLEN
+1.84%
1,689.40
JBCH
+1.80%
14,896.00
SLIN
-0.79%
387.75
BAJE
-0.50%

FAQ

What Stock Exchange Does Eris Lifesciences Ltd Trade On?

Eris Lifesciences Ltd is listed and trades on the Bombay Stock Exchange stock exchange.

What Is the Stock Symbol for Eris Lifesciences Ltd?

The stock symbol for Eris Lifesciences Ltd is "ERIS."

What Is the Eris Lifesciences Ltd Market Cap?

As of today, Eris Lifesciences Ltd market cap is 229.59B.

What Is Eris Lifesciences Ltd's Earnings Per Share (TTM)?

The Eris Lifesciences Ltd EPS (TTM) is 28.41.

When Is the Next Eris Lifesciences Ltd Earnings Date?

Eris Lifesciences Ltd will release its next earnings report on 04 Nov 2025.

From a Technical Analysis Perspective, Is ERIS a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Eris Lifesciences Ltd Stock Split?

Eris Lifesciences Ltd has split 0 times.

How Many Employees Does Eris Lifesciences Ltd Have?

Eris Lifesciences Ltd has 3354 employees.

What is the current trading status of Eris Lifesciences Ltd (ERIS)?

As of 07 Aug 2025, Eris Lifesciences Ltd (ERIS) is trading at a price of 1,694.50, with a previous close of 1,725.45. The stock has fluctuated within a day range of 1,671.10 to 1,725.85, while its 52-week range spans from 1,120.35 to 1,909.55.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.